The use of vaccinations in patients with multiple sclerosis

Infections in Medicine

Volumn 19, Issue 2, 2002, Pages 73-79

  Jeffery, Douglas R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatitis B; Influenza; MRI; Multiple sclerosis; Vaccination

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; BETA1A INTERFERON; CORTICOSTEROID; GADOLINIUM; GLATIRAMER; HEPATITIS B VACCINE; INFLUENZA VACCINE; INTERFERON BETA SERINE; MEASLES MUMPS RUBELLA VACCINE; METHOTREXATE; PLACEBO; POLIOMYELITIS VACCINE; RABIES VACCINE; RECOMBINANT GAMMA INTERFERON; SMALLPOX VACCINE; TYPHOID VACCINE; YELLOW FEVER VACCINE;

ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DEMYELINATION; DETERIORATION; DRUG SAFETY; ENCEPHALITIS; HUMAN; IMMUNE SYSTEM; INFLUENZA VACCINATION; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; NEUROTOXICITY; OPTIC NERVE DISEASE; PROSPECTIVE STUDY; RELAPSE;

EID: 0036188240     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. How many people in the world have multiple sclerosis?
2. Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology
3. Lesions of multiple sclerosis
4. Axonal transection in the lesions of multiple sclerosis
5. Clinical viral infections and multiple sclerosis
6. Influence of infection on exacerbations of multiple sclerosis
7. Triggering factors in multiple sclerosis
8. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations?
9. Exacerbations of multiple sclerosis in patients treated with gamma interferon
10. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis
11. Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis
12. Swine influenza virus vaccination in patients with multiple sclerosis
13. Swine flu vaccine and multiple sclerosis
14. Swine influenza vaccination in patients with multiple sclerosis
15. Defining the clinical course of multiple sclerosis
16. The natural history of multiple sclerosis: A geographically based study
17. Multiple sclerosis: Histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy
18. Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration
19. Commentary: Interferon β therapy for multiple sclerosis
20. Hazard of influenza vaccine in neurologic patients
21. Large focal tumor-like demyelination lesion of the brain: Intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients
22. Neurological complications of swine influenza vaccination
23. Influenza vaccination in multiple sclerosis
24. Serial magnetic resonance imaging studies with paramagnetic contrast medium: Assessment of disease activity in patients with multiple sclerosis before and after influenza vaccination
25. Influenza immunization in multiple sclerosis
26. Swine-influenza vaccine
27. A shadow falls on hepatitis B vacination effort
28. Multiple sclerosis and hepatitis B vaccine?
29. Encephalitis after hepatitis B vaccination: Recurrent disseminated encephalitis or MS?
30. Central nervous system demyelination after vaccination against hepatitis B and HLA haplotype
31. Transverse myelitis following hepatitis B vaccination
32. Hepatitis B vaccine and neurotoxicity
33. MR imaging in a case of postvaccination myelitis
34. Central nervous-system demyelination after immunization with recombinant hepatitis B vaccine
35. Cellulitis associated with bacteremia due to Lavobacterium meningosepticum
36. Post-marketing surveillance for neurologic adverse events reported after hepatitis B vaccination
37. Acute transverse myelitis: Differentation of cases caused by multiple sclerosis and para-infectious mechanisms
38. Immunologic mechanisms in multiple sclerosis: Exacerbation by type A hepatitis and skin test antigens
39. Recurrent demyelinating transverse myelitis in a high titer HBs-antigen carrier
40. Development of multiple sclerosis after hepatitis B vaccination: An immunologic case report
41. Demyelinating disease and hepatitis B vaccination: Survey of 735 patients seen at an MS clinic
42. Demyelination, multiple sclerosis, and hepatitis B vaccination: A population-based study in the UK
43. Vaccinations and the risk of relapse in multiple sclerosis
44. Transverse myelitis after measles, mumps, and rubella vaccine
45. Transverse myelitis unlikely to be due to measles, mumps, and rubella vaccine
46. The role of infection and vaccination in the genesis of optic neuritis and multiple sclerosis in children
47. Adverse Events Associated With Childhood Vaccines: Evidence Bearing on Causality
48. Measles vaccines: A review of adverse events
49. Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: A review of claims, submitted to the National Vaccine Injury Compensation Program
50. The varicella zoster virus: A pilot trial of a potential therapeutic agent in multiple sclerosis
51. Measles vaccination does not prevent multiple sclerosis
52. Multiple sclerosis and vaccination